Bardwick P A, Zvaifler N J, Gill G N, et al. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature[J]. Medicine (Baltimore), 1980,59(4):311-322.
[2]
Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan[J]. Neurology, 1984,34(6):712-720.
[3]
Nasu S, Misawa S, Sekiguchi Y, et al. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy[J]. J Neurol Neurosurg Psychiatry, 2012,83(5):476-479.
[4]
Dispenzieri A, Kyle R A, Lacy M Q, et al. POEMS syndrome: definitions and long-term outcome[J]. Blood, 2003,101(7):2496-2506.
[5]
Dispenzieri A. POEMS syndrome: 2021 Update on diagnosis, risk-stratification, and management[J]. Am J Hematol, 2021,96(7):872-888.
[6]
Brown R, Ginsberg L. POEMS syndrome: clinical update[J]. J Neurol, 2019,266(1):268-277.
Ali T, Qazilbash M H. POEMS syndrome: a multisystem clonal disorder[J]. Eur J Haematol, 2021,106(1):14-18.
[10]
Shao Y, Zhang C, Wang X, et al. A retrospective analysis of endocrinopathy manifestations in 136 Chinese patients with POEMS syndrome[J]. Neuro Endocrinol Lett, 2021,42(5):292-296.
[11]
Dispenzieri A. How I treat POEMS syndrome[J]. Blood, 2012,119(24):5650-5658.
[12]
Li J, Zhang W, Jiao L, et al. Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome[J]. Blood, 2011,117(24):6445-6449.
[13]
Cheng S, Huang L, Fan W, et al. Efficacy of novel agents in patients with nephropathy associated with POEMS syndrome[J]. Int Urol Nephrol, 2022,54(9):2317-2325.
He H, Fu W, Du J, et al. Successful treatment of newly diagnosed POEMS syndrome with reduced-dose bortezomib based regimen[J]. Br J Haematol, 2018,181(1):126-128.
[16]
Cook G, Iacobelli S, van Biezen A, et al. High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the plasma cell disorder sub-committee of the chronic malignancy working party of the european society for blood & marrow transplantation[J]. Haematologica, 2017,102(1):160-167.
2023, Vol. 34 
